Clinical features of 26 cases of COVID-19-associated conjunctivitis

Asahi Tajima, Yukio Sassa, Daiki Ishio, Shota Yamashita, Eiji Sadashima, Rikki Arai, Kentaro Iwanaga, Shigeo Yoshida, Koh Hei Sonoda, Hiroshi Enaida

研究成果: ジャーナルへの寄稿学術誌査読

1 被引用数 (Scopus)

抄録

Purpose: To explore the clinical features of COVID-19-associated conjunctivitis with the objective of preventing the spread of infection. Study design: Retrospective cohort study. Methods: From March 2020 to March 2021, we retrospectively reviewed 26 (9.8%) consecutive COVID-19 patients with conjunctivitis among 282 COVID-19 cases admitted to our hospital. Clinical symptoms, onset date of conjunctivitis, time to patient recovery, and eye drop intervention were investigated. In addition, risk factors for developing conjunctivitis were statistically examined among 206 inpatients available for within 5 days of the onset. A multivariate analysis of conjunctivitis risk factors was performed. Results: Among the 282 COVID-19 patients, 4 (1.4%) had conjunctival hyperemia as the primary symptom. The median time of onset was 4 days after the COVID-19 onset. Hyperemia was observed in all cases, but other ocular symptoms were rare. The median duration of hyperemia was 3 days. A multiple logistic regression analysis revealed that a young age (p=0.005) and current smoking habit (p=0.027) were independent risk factors for conjunctivitis after COVID-19. Conclusions: COVID-19-associated conjunctivitis is rare in the elderly and strongly associated with a history of smoking. It often occurs in the early stages of infection, and while hyperemia is recognized as a clinical symptom, other ocular symptoms are rare or non-existent. Many cases recover within a short time.

本文言語英語
ページ(範囲)57-63
ページ数7
ジャーナルJapanese Journal of Ophthalmology
68
1
DOI
出版ステータス出版済み - 1月 2024

!!!All Science Journal Classification (ASJC) codes

  • 眼科学

フィンガープリント

「Clinical features of 26 cases of COVID-19-associated conjunctivitis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル